Matty Weijenberg
Matty Weijenberg is a professor of Molecular Epidemiology of Cancer and the chair of the department of Epidemiology at Maastricht University (UM). Her research is part of the programme Prevention of the GROW research institute for oncology and reproduction at UM.
She is the principal investigator of the Energy for life after ColoRectal cancer study (the EnCoRe study), a prospective cohort study focused on investigating the importance of lifestyle factors (diet, nutrition, physical (in)activity and body composition) for the prognosis and quality of life of people living with and beyond colorectal cancer. There is a special interest in fatigue and chemotherapy induced peripheral neuropathy (CIPN).
EnCoRe is also part of international consortia of colorectal cancer survivorship studies. One is on biomarkers related to FOlate-dependent one-carbon metabolism in Colorectal cancer recUrrence and Survival (FOCUS).
The other is the METABOlic profiles across the Continuum of Colorectal Cancer consortium (MetaboCCC). Within the nationwide prospective Netherlands Cohort Study on diet and cancer (NLCS), Matty Weijenberg is also involved in research on the importance of lifestyle factors in relation to the incidence and prognosis of colorectal cancer while accounting for (epi)genetic tumour heterogeneity and genetic variation.
Matty Weijenberg is currently deputy chair of World Cancer Research Fund (WCRF) International’s Global Cancer Update Programme (CUP Global) which is the flagship research programme of the WCRF network and provides a global analysis of scientific research into the link between diet, physical activity, weight and cancer. It is produced in partnership with American Institute for Cancer Research (AICR), WCRF in the UK and Wereld Kanker Onderzoek Fonds (WKOF) in The Netherlands.
In addition, she is a member of the Working group on Lifestyle for the development of the 5th Edition of the European Code Against Cancer within the broader framework of the World Code Against Cancer, launched by the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO).